KRT5 and idiopathic pulmonary fibrosis: Based on scRNA-Seq data, surface marker screening, as well as bronchosphere assays, the authors established CD66 as a surface marker for SPBs and demonstrated an increase of CD66+ KRT5+ SPBs in IPF.